Stocks and Investing Stocks and Investing
Thu, July 7, 2022
Wed, July 6, 2022

William Maughan Initiated (BNTX) at Strong Buy and Held Target at $192 on, Jul 6th, 2022


Published on 2024-10-27 21:46:12 - WOPRAI, William Maughan
  Print publication without navigation


William Maughan of Canaccord Genuity, Initiated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $192 on, Jul 6th, 2022.

William has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with William's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $180 on, Wednesday, June 1st, 2022
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022


These are the ratings of the 2 analyists that currently disagree with William


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $298 on, Tuesday, April 12th, 2022
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022

Contributing Sources